GlassScriptPhysician profile
Camryn Rabourn
NPI 1316502883
$497.15
in general payments reported to CMS, 2019-2025
10 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $198 · 2023: $79.09 · 2024: $81.91 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $203.18 | 2022-2023 | Omega |
| Treace Medical Concepts, INC. | $99.48 | 2025 | |
| Orthofix Medical, INC. | $40.09 | 2023-2024 | Physio-Stim, Accelstim, Spinal-Stim |
| Novus Surgical Consultants | $38.81 | 2025 | |
| Medartis INC. | $38.73 | 2024 | Aptus |
| Depuy Synthes Sales INC. | $19.20 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.81 | 2024 | Nuzyra |
| Bioventus LLC | $14.25 | 2022 | |
| Sanara Medtech INC. | $13.96 | 2023 | Celleraterx |
| Novus Surgical Solutions LLC | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Camryn Rabourn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.